Tech Company Financing Transactions
Capricor Therapeutics Funding Round
Private investors invested in a $10 million funding round for Capricor Therapeutics. The funding round was recorded on 2/4/2015.
Transaction Overview
Company Name
Announced On
2/4/2015
Transaction Type
Venture Equity
Amount
$10,002,028
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
8840 Wilshire Blvd. 2nd Floor
Beverly Hills, CA 90211
USA
Beverly Hills, CA 90211
USA
Phone
Website
Email Address
Overview
Capricor Therapeutics, Inc. (Nasdaq:CAPR) is a clinical-stage biotechnology company focused on the discovery, development, and commercialization of first-in-class biological therapeutics for the treatment of cardiac and other serious medical conditions.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Linda Marban
Vice President
Luis Martinez
VP - Client Services
Jeffrey Rudy
VP - Finance
AJ Bergmann
VP - General Counsel
Karen Krasney
Browse more venture capital transactions:
Prev: 2/4/2015: Crushpath venture capital transaction
Next: 2/4/2015: Catalyst Biosciences venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs